Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 11 Mar 2024
News, features, and opinions on matters pertaining to cancer.
Read Full NewsFrank Sciurba, MD, reports tozorakimab improved E-RS:COPD scores vs placebo at week 52 in OBERON and TITANIA, including breathlessness and chest symptoms.
Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD
Joanna Wardlaw, MD, Professor of Applied Neuroimaging at the University of Edinburgh, discusses the evolving understanding of cerebral small vessel disease, emerging therapeutic approaches, and the makings behind a successful trial.
Paul Melmeyer, MPP, Executive Vice President of Public Policy and Advocacy at the Muscular Dystrophy Association, discusses the Neuromuscular Advocacy Collaborative, its growing year-round presence, and what the group hopes to accomplish heading into the 2027 MDA Clinical and Scientific Conference.
The Editor-in-Chief of the Journal of the American Heart Association discussed what journal editors look for in stroke research submissions, how AI and open access are reshaping publishing, and the equity gaps that still exist for researchers in lower-income countries.
Mitzi Joi Williams, MD, is joined by Temitope Adeola, MD, and Chantale Branson, MD, to discuss migraine as a complex neurological condition, including recognizing symptoms and triggers, navigating acute and preventive treatment options, and incorporating lifestyle modifications to improve migraine management.
A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.
1.
Males with early-onset colorectal cancer are at risk, according to a study.
2.
FDA Panel Endorses Capivasertib Use in Prostate Cancer
3.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
4.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
5.
Year in Review: Chronic Lymphocytic Leukemia
1.
The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025
2.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
3.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
4.
Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern
5.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Hematologists Evaluate Persistent Blood Abnormalities
2.
Understanding the Difference Between Iron Deficiency and Other Types of Anemia
3.
Efficient Management of First line ALK-rearranged NSCLC - Part V
4.
Efficient Management of First line ALK-rearranged NSCLC - Part III
5.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge